Administration - FDA Approves Intravenous Formulation Of Pfizer’s Revatio® (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension

Administration - FDA Approves Intravenous Formulation Of Pfizer’s Revatio® (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension
Ad-Hoc-News - 28 minutes ago
Pfizer announced today that the US Food and Drug Administration (FDA) has approved Revatio® (sildenafil) Injection, an intravenous formulation of Revatio Revatio is the only FDA-approved ...
FDA Approves Intravenous Formulation Of Pfizer's Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension - Trading Markets
Pfizer Says FDA Approves Intravenous Formulation Of Revatio For Treatment Of Pulmonary Arterial Hypertension - Quick Facts - RTT News